Tomohisa Mori Selected Research

Naloxone (Narcan)

7/2015	Involvement of μ- and δ-opioid receptor function in the rewarding effect of (±)-pentazocine.
10/2014	Involvement of 5-HT2 receptors in the expression of withdrawal diarrhea in morphine-dependent mice.
9/2013	Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of μ-opioid receptor agonist-induced physical dependence.
12/2007	Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomohisa Mori Research Topics

Disease

12	Pain (Aches) 01/2021 - 09/2009
7	Neuralgia (Stump Neuralgia) 07/2022 - 01/2014
6	Substance-Related Disorders (Drug Abuse) 01/2022 - 12/2004
4	Neoplasms (Cancer) 04/2024 - 09/2009
4	Schizophrenia (Dementia Praecox) 01/2022 - 02/2012
4	Hyperalgesia 01/2022 - 01/2014
4	Body Weight (Weight, Body) 10/2014 - 08/2006
3	Hallucinations (Hallucination) 01/2022 - 01/2012
2	Chronic Pain 08/2023 - 01/2022
2	Rupture 01/2018 - 07/2007
2	Constipation 01/2016 - 10/2013
2	Narcolepsy 01/2016 - 03/2010
2	Bone Neoplasms (Bone Cancer) 04/2015 - 01/2014
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 10/2014 - 09/2013
2	Diarrhea 10/2014 - 09/2013
2	Acquired Immunodeficiency Syndrome (AIDS) 06/2013 - 12/2011
2	HIV Infections (HIV Infection) 07/2012 - 12/2011
1	Sarcopenia 04/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024
1	Inflammation (Inflammations) 04/2024
1	Cachexia 04/2024
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Postoperative Pain 01/2021
1	Breakthrough Pain 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2016
1	Sleep Wake Disorders 01/2016
1	Hypersensitivity (Allergy) 04/2015
1	Muscle Rigidity 01/2014
1	Parkinsonian Disorders (Parkinsonism) 06/2012
1	Parkinson Disease (Parkinson's Disease) 06/2012

Drug/Important Bio-Agent (IBA)

12	Morphine (MS Contin)FDA LinkGeneric 07/2022 - 07/2007
11	Opioid Receptors (Opioid Receptor)IBA 07/2022 - 11/2012
5	Opioid Analgesics (Opioids)IBA 07/2022 - 12/2004
5	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 06/2012
5	Oxycodone (Oxycontin)FDA LinkGeneric 04/2015 - 09/2013
4	Messenger RNA (mRNA)IBA 04/2024 - 07/2015
4	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2018 - 07/2007
4	Fentanyl (Sublimaze)FDA LinkGeneric 01/2017 - 09/2013
4	Naloxone (Narcan)FDA LinkGeneric 07/2015 - 12/2007
3	Narcotic Antagonists (Opioid Antagonists)IBA 07/2015 - 09/2013
3	FullerenesIBA 10/2014 - 08/2006
2	CorticosteroneIBA 04/2024 - 01/2023
2	((3- methoxythiophen- 2- yl)methyl)((2- (9- (pyridin- 2- yl)- 6- oxaspiro(4.5)decan- 9- yl)ethyl))amineIBA 01/2021 - 01/2017
2	Illicit Drugs (Recreational Drugs)IBA 01/2018 - 01/2012
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2018 - 01/2012
2	Phencyclidine (Angel Dust)IBA 01/2018 - 01/2012
2	Ketamine FDA LinkGeneric 01/2018 - 01/2012
2	OrexinsIBA 01/2016 - 03/2010
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2016 - 01/2007
2	Pentazocine (Talwin)FDA LinkGeneric 07/2015 - 03/2015
2	LigandsIBA 03/2015 - 06/2012
2	Sigma-1 ReceptorIBA 03/2015 - 09/2009
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014 - 01/2014
2	naloxonazineIBA 10/2013 - 09/2013
2	N-methylnaloxoneIBA 10/2013 - 09/2013
2	Cocaine (Cocaine HCl)IBA 07/2012 - 12/2011
1	Lipocalin-2IBA 04/2024
1	EndotoxinsIBA 04/2024
1	CytokinesIBA 04/2024
1	LipopolysaccharidesIBA 04/2024
1	GlucocorticoidsIBA 01/2023
1	G Protein-Coupled Inwardly-Rectifying Potassium ChannelsIBA 07/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2022
1	QuinpiroleIBA 01/2022
1	GSK-J4IBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	Histones (Histone)IBA 01/2021
1	AnnexinsIBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	Cornified Envelope Proline-Rich ProteinsIBA 01/2021
1	PLIalphaIBA 01/2018
1	CannabinoidsIBA 01/2018
1	Therapeutic UsesIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2016
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 01/2016
1	5-HT1A Serotonin ReceptorIBA 01/2016
1	pre-prodynorphinIBA 07/2015
1	naltrindoleIBA 07/2015
1	Formaldehyde (Formol)FDA Link 07/2015
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 10/2014
1	Ondansetron (Zofran)FDA LinkGeneric 10/2014
1	RitanserinIBA 10/2014
1	MuscarineIBA 10/2014
1	Olanzapine (Zyprexa)FDA Link 10/2014
1	Free Radical ScavengersIBA 10/2014
1	Atropine FDA LinkGeneric 10/2014
1	Zolpidem (Ambien)FDA LinkGeneric 09/2014
1	tertiapinIBA 01/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2014
1	BenzodiazepinesIBA 06/2013
1	Anti-Anxiety Agents (Anxiolytics)IBA 06/2013
1	Hypnotics and Sedatives (Sedatives)IBA 06/2013
1	Dronabinol (THC)FDA LinkGeneric 11/2012
1	Cannabinoid Receptor AgonistsIBA 11/2012

Therapy/Procedure

5	Ligation 07/2022 - 01/2016
2	Transplantation 04/2024 - 01/2022
1	Exercise Therapy (Therapy, Exercise) 08/2023
1	Electrocoagulation (Electrocautery) 01/2021
1	Therapeutics 07/2012